×
About 5,906 results

ALLMedicine™ Retinal Vein Occlusion Center

Research & Reviews  2,833 results

3-Dimensional Visualization of Arteriovenous Crossing in a Branch Retinal Vein Occlusion.
https://doi.org/10.1016/j.ophtha.2020.09.035
Ophthalmology Lo T, Yiu G

Feb 22nd, 2021 - 3-Dimensional Visualization of Arteriovenous Crossing in a Branch Retinal Vein Occlusion.|2021|Lo T,Yiu G,|

Twenty-Four Month Results of Intravitreal Ranibizumab for Macular Edema after Branch Re...
https://doi.org/10.1080/08820538.2021.1890147
Seminars in Ophthalmology; Inagaki M, Hirano Y et. al.

Feb 22nd, 2021 - Purpose: To report 24-month results after one intravitreal ranibizumab (IVR) injection followed by pro re nata (PRN) dosing for macular edema (ME) after branch retinal vein occlusion (BRVO). Methods: Eyes with BRVO met the followings were included...

Treatment outcomes of retinal vein occlusion in clinical practice in Nepal.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890616
BMC Ophthalmology; Bhandari S, Poudel M et. al.

Feb 19th, 2021 - This study evaluated the treatment outcomes of retinal vein occlusion (RVO) in a routine clinical practice in Nepal. This was a retrospective analysis of observational data of patients with RVO who attended the retina clinic of the Tilganga Instit...

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend for Macular Edema in C...
https://doi.org/10.1016/j.ajo.2021.01.027
American Journal of Ophthalmology; Korobelnik JF, Larsen M et. al.

Feb 8th, 2021 - To evaluate the efficacy and safety of intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E) dosing in patients with macular edema secondary to central retinal vein occlusion (CRVO). CENTERA was an open-label, Phase 4 clinical study. Patients ...

Multimodal imaging of two cases of retinal vein occlusion secondary to Waldenstrom macr...
https://doi.org/10.1177/1120672121991389
European Journal of Ophthalmology; Remolí Sargues L, Montero Hernández J et. al.

Feb 4th, 2021 - To report multimodal imaging characteristics of two cases of retinal vein occlusion (RVO) secondary to Waldenstrom macroglobulinemia (WM). Case 1: An 82-year-old woman presented with vision loss. She had a history of WM. Best-corrected visual acui...

see more →

Guidelines  1 results

Therapies for Macular Edema Associated with Branch Retinal Vein Occlusion: A Report by the A...
https://www.aaojournal.org/article/S0161-6420(17)30980-6/fulltext
Justis P. Ehlers

Aug 31st, 2017 - Current level I evidence suggests that intravitreal pharmacotherapy with anti-VEGF agents is effective and safe for ME secondary to BRVO. Prolonged delay in treatment is associated with less improvement in visual acuity (VA).

see more →

Drugs  4 results see all →

Clinicaltrials.gov  2,957 results

3-Dimensional Visualization of Arteriovenous Crossing in a Branch Retinal Vein Occlusion.
https://doi.org/10.1016/j.ophtha.2020.09.035
Ophthalmology Lo T, Yiu G

Feb 22nd, 2021 - 3-Dimensional Visualization of Arteriovenous Crossing in a Branch Retinal Vein Occlusion.|2021|Lo T,Yiu G,|

Twenty-Four Month Results of Intravitreal Ranibizumab for Macular Edema after Branch Re...
https://doi.org/10.1080/08820538.2021.1890147
Seminars in Ophthalmology; Inagaki M, Hirano Y et. al.

Feb 22nd, 2021 - Purpose: To report 24-month results after one intravitreal ranibizumab (IVR) injection followed by pro re nata (PRN) dosing for macular edema (ME) after branch retinal vein occlusion (BRVO). Methods: Eyes with BRVO met the followings were included...

Treatment outcomes of retinal vein occlusion in clinical practice in Nepal.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890616
BMC Ophthalmology; Bhandari S, Poudel M et. al.

Feb 19th, 2021 - This study evaluated the treatment outcomes of retinal vein occlusion (RVO) in a routine clinical practice in Nepal. This was a retrospective analysis of observational data of patients with RVO who attended the retina clinic of the Tilganga Instit...

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend for Macular Edema in C...
https://doi.org/10.1016/j.ajo.2021.01.027
American Journal of Ophthalmology; Korobelnik JF, Larsen M et. al.

Feb 8th, 2021 - To evaluate the efficacy and safety of intravitreal aflibercept (IVT-AFL) treat-and-extend (T&E) dosing in patients with macular edema secondary to central retinal vein occlusion (CRVO). CENTERA was an open-label, Phase 4 clinical study. Patients ...

Multimodal imaging of two cases of retinal vein occlusion secondary to Waldenstrom macr...
https://doi.org/10.1177/1120672121991389
European Journal of Ophthalmology; Remolí Sargues L, Montero Hernández J et. al.

Feb 4th, 2021 - To report multimodal imaging characteristics of two cases of retinal vein occlusion (RVO) secondary to Waldenstrom macroglobulinemia (WM). Case 1: An 82-year-old woman presented with vision loss. She had a history of WM. Best-corrected visual acui...

see more →

News  109 results

Retinal Vein Occlusion Clinical Practice Guidelines (2019)
https://reference.medscape.com/viewarticle/917394

Sep 2nd, 2019 - In August 2019, the European Society of Retina Specialists (EURETINA) published clinical practice guidelines on the management of retinal vein occlusion (RVO).[1] Patients with suspected retinal vein occlusion (RVO) should undergo a full ophthalmo...

FDA Okays Aflibercept (Eylea) for Diabetic Retinopathy
https://www.staging.medscape.com/viewarticle/913006

May 13th, 2019 - The US Food and Drug Administration (FDA) has approved aflibercept (Eylea, Regeneron Pharmaceuticals) injection solution to treat all stages of diabetic retinopathy, the manufacturer has announced. Aflibercept, a vascular endothelial growth factor...

FDA OKs Aflibercept (Eylea) for Diabetic Retinopathy
https://www.medscape.com/viewarticle/913006

May 13th, 2019 - The US Food and Drug Administration (FDA) has approved aflibercept (Eylea, Regeneron) injection solution to treat all stages of diabetic retinopathy, the manufacturer has announced. Aflibercept, a vascular endothelial growth factor (VEGF) inhibito...

Anti-VEGF Tx Seems OK for Eye Disorders
https://www.medpagetoday.com/ophthalmology/generalophthalmology/71990

Mar 25th, 2018 - Intravitreal anti-VEGF treatments for neovascular age-related macular degeneration (AMD), diabetic macular edema (DME), or retinal vein occlusion did not appear to increase the risk of systemic adverse events, particularly cardiovascular adverse e...

A Guide To Managing RVO: Ophthalmology Times
https://www.medpagetoday.com/ophthalmology/generalophthalmology/70255

Jan 2nd, 2018 - One expert discusses options for managing retinal vein occlusion over the long-term in patients with macular edema. A recent study reported that visual acuity did not improve when patients with diabetic macular edema received corticosteroid implan...

see more →

Patient Education  2 results see all →